Long-Term Cost of Growth Hormone Treatments in Kids

One of the most important questions parents ask when exploring treatment options is:

“How much will growth hormone therapy cost over the long term?”

This is an important question because growth hormone treatment is rarely a short-term commitment. Unlike many medications that are prescribed for a few weeks or months, pediatric growth hormone therapy may continue for several years while a child is actively growing.

Families researching the long-term cost of growth hormone treatments in kids are often surprised to learn that the total financial commitment can extend well beyond the initial consultation or first prescription.

Medication is usually one of the largest expenses, but the complete cost of treatment may also include:

• Growth evaluations
• Laboratory testing
• Bone age X-rays
• Follow-up appointments
• Growth hormone medication
• Injection supplies
• Insurance deductibles and copays
• Specialty pharmacy expenses
• Ongoing monitoring

Because treatment may continue for years, even relatively small differences in monthly expenses can become significant over the course of childhood.

Understanding the complete financial picture—including treatment duration, medication costs, monitoring requirements, insurance coverage, and follow-up care—can help parents make informed decisions about their child's growth journey.

At HGH for Children, we believe families should understand not only how treatment works, but also what they may need to plan for financially over time.

How Much Does Growth Hormone Treatment Cost for a Child?

There is no single price that applies to every child receiving growth hormone therapy.

The total cost can depend on:

• The child's diagnosis
• Body weight
• Prescribed dose
• Growth hormone formulation
• Pharmacy pricing
• Daily versus long-acting medication
• Duration of treatment
• Insurance coverage
• Deductibles and coinsurance
• Specialty pharmacy benefits
• Laboratory and monitoring expenses
• Whether treatment is insurance-based or cash-pay

For this reason, two children receiving growth hormone can have very different monthly and annual expenses.

One family may have substantial insurance coverage and primarily pay deductibles, copays, or coinsurance. Another family may be responsible for most or all of the medication cost.

The better question is therefore not simply:

“How much does HGH cost?”

Instead, families should ask:

“What will my child's entire growth hormone treatment plan potentially cost over the years that treatment may be needed?”

Why Growth Hormone Therapy Often Continues for Years

Growth hormone treatment is intended to support growth while a child's growth plates remain open and there is an appropriate medical reason to continue therapy.

Depending on the diagnosis and response to treatment, therapy may continue until one or more of the following occurs:

• Growth plates approach or reach closure
• Near-final adult height is reached
• Growth velocity slows significantly
• Treatment goals are achieved
• Treatment is no longer producing sufficient benefit
• The treating clinician determines that therapy should be discontinued

Because growth continues throughout childhood and adolescence, some children may remain on therapy for:

• Several years during childhood
• Through part of adolescence
• Longer in certain medically appropriate situations

Other children may have considerably shorter treatment courses.

Treatment duration depends on factors such as:

• Age when treatment begins
• Bone age
• Diagnosis
• Pubertal stage
• Growth velocity
• Response to therapy
• Remaining growth potential

This is why families should evaluate the long-term cost of growth hormone treatment rather than focusing only on the price of the first month.

What Conditions May Lead to Growth Hormone Treatment?

Growth hormone therapy is not appropriate for every child with short stature.

Before treatment is considered, clinicians evaluate why the child is growing slowly and whether a medical condition is affecting normal growth.

Conditions and findings that may be investigated include:

• growth hormone deficiency
• idiopathic short stature
• constitutional growth delay
• low IGF-1
• pituitary disorders
• Certain genetic or chromosomal growth disorders
• Children born small for gestational age who do not demonstrate appropriate catch-up growth
• Certain chronic medical conditions associated with impaired growth

It is important to distinguish between a finding that warrants further evaluation and a diagnosis that establishes an indication for growth hormone therapy.

For example, low IGF-1 alone does not prove growth hormone deficiency.

Likewise, constitutional growth delay does not automatically mean a child requires growth hormone treatment.

Many children evaluated for slow growth ultimately do not require therapy.

This is why a comprehensive pediatric growth evaluation appointment should occur before families make decisions about long-term treatment costs.

Determining why a child is growing slowly should come before determining how much treatment might cost.

What Makes Pediatric Growth Hormone Treatment Expensive?

Recombinant human growth hormone is a biologic medication and is considerably more complex to manufacture than many conventional medications.

Several factors contribute to the overall cost.

Growth Hormone Medication

The medication itself is generally one of the largest treatment expenses.

Pricing can vary according to:

• Medication
• Manufacturer
• Pharmacy
• Prescribed dose
• Insurance formulary
• Pharmacy benefits
• Patient assistance programs
• Daily versus long-acting formulation

Treatment May Continue for Years

Even when monthly expenses appear manageable, several years of therapy can create a substantial cumulative expense.

Children Grow and Gain Weight

Pediatric growth hormone dosing is commonly influenced by body weight and the child's clinical circumstances.

As children grow, their medication requirements may change.

This means the amount of medication required early in treatment may not be the same as the amount needed several years later.

Ongoing Medical Monitoring Is Necessary

Growth hormone treatment should not simply be prescribed and renewed indefinitely without appropriate monitoring.

Children receiving treatment generally require periodic assessment of:

• Height
• Weight
• Growth velocity
• Pubertal development
• IGF-1
• Treatment response
• Possible side effects
• Other laboratory markers when appropriate
• Bone age when clinically indicated

These services contribute to the overall cost of treatment.

What Is the Average Cost of Growth Hormone Therapy for Kids?

Parents frequently search for the average cost of HGH for children, but there is no single national price that accurately represents every patient's experience.

Published medical and health-economic research has consistently demonstrated that recombinant growth hormone can be an expensive long-term pediatric therapy.

However, the actual amount paid by a family varies substantially.

Depending on the child's treatment circumstances, the combined cost of medication and medical care can reach many thousands of dollars per year and, in some circumstances, tens of thousands of dollars annually.

Some published economic analyses have estimated substantial cumulative costs over several years of therapy.

However, older studies should not be interpreted as current pharmacy price lists because medication pricing, insurance coverage, available formulations, and treatment models change over time.

For families considering treatment today, an individualized medication estimate based on the child's actual prescription is far more useful than relying on a generic national average found online.

How Much Does Growth Hormone Cost Per Month?

Monthly growth hormone cost varies considerably.

There is no universal monthly price because pediatric treatment is individualized.

Factors affecting monthly medication expense include:

• Child's weight
• Prescribed dose
• Medication formulation
• Pharmacy
• Insurance coverage
• Deductible
• Coinsurance
• Manufacturer assistance
• Treatment indication

Without substantial insurance coverage, growth hormone medication may cost hundreds of dollars per month or considerably more, depending on the treatment plan.

Medical management, laboratory testing, and other treatment expenses may be separate.

Parents should therefore request an estimate of the total expected monthly out-of-pocket cost, rather than looking only at the listed price of the medication.

Why Growth Hormone Costs Can Increase as a Child Gets Older

One factor families sometimes overlook is that pediatric growth hormone dosing can be influenced by body weight.

As children grow:

• Body weight increases
• Medication requirements may change
• Monthly medication use may increase
• Overall medication expenses may rise

A younger child weighing substantially less may require a different amount of medication than an adolescent receiving treatment several years later.

This means the first year's treatment expense should not automatically be multiplied by the expected number of treatment years and assumed to represent the exact final cost.

Puberty Can Change Treatment Requirements

Puberty introduces additional variables.

Children experience significant changes in:

• Body weight
• Growth velocity
• Sex hormones
• IGF-1
• Skeletal maturation

Treatment plans may therefore be reassessed as children progress through adolescence.

Medication Prices Can Change

Growth hormone therapy may continue for years, and pharmacy pricing does not necessarily remain constant during that period.

Medication costs may change because of:

• Manufacturer pricing
• Pharmacy changes
• Insurance formulary changes
• New medication options
• Changes in coverage

Understanding Multi-Year Growth Hormone Treatment Costs

The most important financial concept for families is that relatively modest annual expenses become much larger when treatment continues for several years.

For example, if total treatment expenses were hypothetically:

$10,000 per year

then:

• 3 years = $30,000
• 5 years = $50,000
• 7 years = $70,000

If expenses were:

$20,000 per year

then:

• 3 years = $60,000
• 5 years = $100,000
• 7 years = $140,000

And if treatment expenses were higher, cumulative costs would rise accordingly.

These examples are illustrative calculations only. They are not estimates of what a particular child will pay.

Actual treatment expenses can increase or decrease because of:

• Dose changes
• Weight changes
• Insurance coverage
• Medication changes
• Pharmacy pricing
• Monitoring requirements
• Treatment duration

The purpose of these examples is to demonstrate why families should think about multi-year cost, rather than simply asking what the first prescription costs.

Five-Year Growth Hormone Cost

Five years is a useful example because some children may remain on growth hormone treatment for several years.

The total five-year cost depends heavily on annual expense.

For example:

Illustrative Annual Cost	Illustrative 5-Year Cost
$10,000	$50,000
$15,000	$75,000
$20,000	$100,000
$25,000	$125,000
$30,000	$150,000

These are simple mathematical examples rather than quoted treatment prices.

The actual five-year cost for an individual child may be substantially different.

Seven-Year Growth Hormone Cost

Children who begin treatment earlier may potentially remain on therapy for a longer period.

Illustrative seven-year calculations demonstrate how treatment duration changes cumulative expense:

Illustrative Annual Cost	Illustrative 7-Year Cost
$10,000	$70,000
$15,000	$105,000
$20,000	$140,000
$25,000	$175,000
$30,000	$210,000

Again, these calculations do not represent guaranteed treatment prices.

Their purpose is to help parents understand why the long-term financial commitment can become substantial.

Does Starting Growth Hormone Earlier Cost More?

Potentially.

Beginning treatment at a younger age may mean a child remains on therapy for a longer period.

More years of treatment generally means greater cumulative medication and medical-management expenses.

However, treatment decisions should not be based solely on cost.

For appropriately diagnosed children, beginning treatment while substantial growth potential remains may provide more time for treatment to influence growth.

Parents and clinicians should consider:

• Diagnosis
• Age
• Bone age
• Growth velocity
• Pubertal stage
• Expected treatment response
• Remaining growth potential
• Likely treatment duration
• Financial burden

The appropriate treatment window is individualized.

Why a Growth Evaluation Matters Before Considering Cost

The financial discussion should always follow the more important medical question:

Does this child actually need treatment?

Many children referred for growth concerns are ultimately found to have:

• growth delay vs late bloomer kids
• Normal family growth patterns
• Delayed puberty
• Constitutional growth delay
• Adequate future growth potential

Some children require only monitoring.

Others may have a medical condition affecting growth that requires an entirely different treatment.

Families may begin answering these questions after a child height specialist consultation or while searching for a child height specialist near me.

A proper diagnosis can help avoid both unnecessary treatment and unnecessary expense.

What Tests Can Add to the Cost of a Growth Evaluation?

Medication is only one component of pediatric growth care.

Before treatment, a child may undergo testing such as:

• IGF-1
• IGFBP-3
• Thyroid testing
• Complete blood count
• Metabolic testing
• Nutritional testing when indicated
• Celiac screening when appropriate
• Bone age X-ray
• Growth hormone stimulation testing when clinically indicated
• Pituitary MRI in selected cases

Not every child requires every test.

Testing should be based on the child's medical history, growth pattern, physical examination, and initial laboratory findings.

Families should ask whether diagnostic testing, imaging, and ongoing laboratory monitoring are included in a treatment program or billed separately.

The Hidden Costs of Growth Hormone Treatment

When comparing growth hormone programs, parents sometimes focus entirely on medication price.

That can underestimate the true cost.

Additional expenses may include:

Initial Growth Evaluation

A detailed medical evaluation may be required before treatment is considered.

Laboratory Testing

Baseline and follow-up testing may be necessary.

Bone Age Imaging

Bone age X-rays may be used to evaluate skeletal maturity and remaining growth potential.

Follow-Up Appointments

Regular visits help determine whether treatment is producing an appropriate response.

Injection Supplies

Supplies may or may not be included with the medication.

Specialty Pharmacy Expenses

Growth hormone is frequently dispensed through specialty pharmacies.

Travel

Families receiving specialized care outside their immediate area may incur travel expenses.

Insurance Deductibles and Coinsurance

A medication can technically be “covered” while still creating substantial out-of-pocket costs.

This is why parents should ask for the expected total cost of treatment, rather than focusing only on medication.

Does Insurance Cover Growth Hormone for Children?

Sometimes.

Insurance coverage for pediatric growth hormone varies considerably by plan, diagnosis, medication, and medical-necessity criteria.

Insurers may evaluate factors such as:

• Diagnosis
• Height
• Growth velocity
• Laboratory findings
• Growth hormone stimulation testing when indicated
• Bone age
• Medical records
• Treatment history
• Medication formulary

Prior authorization is commonly required.

A child may have a medical reason for treatment but still encounter insurance restrictions.

Coverage can also differ substantially according to diagnosis.

Families should ask their insurance company:

1. Is pediatric growth hormone covered?
2. Which growth hormone medications are preferred?
3. Is prior authorization required?
4. What deductible applies?
5. Is there coinsurance?
6. Must a specific specialty pharmacy be used?
7. Are laboratory tests covered?
8. Are bone age X-rays covered?
9. What happens if the prescribed medication is not on the formulary?

The listed medication price and the amount a family ultimately pays can be dramatically different.

Growth Hormone Cost With Insurance vs. Without Insurance

Insurance coverage can have a major effect on the long-term cost of treatment.

Growth Hormone With Insurance

Depending on the plan, families may be responsible for:

• Copays
• Coinsurance
• Deductibles
• Specialty pharmacy charges
• Non-covered services

The insurer may cover a significant portion of medication expenses when treatment meets plan requirements.

Growth Hormone Without Insurance

Cash-pay families may be responsible for:

• Medication
• Medical management
• Laboratory testing
• Imaging
• Follow-up care
• Supplies

However, cash pricing also varies according to pharmacy, medication, dose, and treatment program.

The most useful comparison is therefore the family's actual annual out-of-pocket expense.

Daily HGH vs. Long-Acting Growth Hormone Cost

Families may encounter both daily and long-acting recombinant growth hormone formulations.

Traditional growth hormone therapy generally involves frequent subcutaneous injections.

Long-acting products are designed to reduce injection frequency.

The financial difference between these options depends on:

• Insurance formulary
• Pharmacy benefits
• Dose
• Medication pricing
• Diagnosis
• Product availability

A long-acting medication should not automatically be assumed to be cheaper or more expensive.

Parents should compare the actual expected annual expense of the medications available to their child.

Can Growth Hormone Costs Change If Insurance Changes?

Yes.

This is especially important because treatment may continue for years.

During that time, families may:

• Change employers
• Change health insurance
• Change pharmacy benefits
• Face a new deductible
• Have a medication removed from the formulary
• Be required to change specialty pharmacies
• Be required to switch medications

Insurance approval at the beginning of treatment does not guarantee that identical coverage will continue for the entire course of therapy.

Long-term financial planning should account for this possibility.

HGH for Children Pricing Model

At HGH for Children, we aim to make the cost of pediatric growth treatment as transparent and predictable as possible.

Treatment Costs

The total cost of care generally includes two primary components:

• Ongoing medical management
• Growth hormone medication

Medication expenses vary considerably from child to child.

Factors such as:

• Body weight
• Prescribed dose
• Treatment plan
• Pharmacy pricing
• Medication formulation
• Duration of therapy

can all affect the monthly expense.

In general, families should expect growth hormone medication to cost several hundred dollars per month or more, with expenses potentially increasing as dosage requirements change.

Medical management and ongoing monitoring represent additional expenses.

Estimated Annual Cost

Because medication requirements vary, there is no single annual price that applies to every child.

For many families, the combined cost of medication and medical management can reach several thousand dollars to well over $10,000 per year, depending on the child's individual treatment requirements.

Families receive more specific cost information once the child's evaluation is complete and an appropriate treatment plan has been established.

All pricing is approximate and subject to change. Medication costs depend on the prescribed treatment, dose, pharmacy, and individual clinical circumstances.

Why Transparent Pricing Matters

Growth hormone therapy may represent a multi-year commitment.

Families therefore benefit from understanding:

• What medical management costs
• What medication may cost
• Which services are included
• Which services are billed separately
• Whether laboratory testing is included
• Whether imaging is included
• How medication pricing may change
• Whether dosage increases could affect cost

Transparent pricing allows families to evaluate treatment based on the complete financial picture rather than an advertised monthly number.

Is Cheaper Growth Hormone Always Better?

No.

Cost is important, particularly when therapy may continue for years, but the lowest advertised price should not automatically determine treatment.

Parents should also consider:

• Whether treatment is medically appropriate
• Medication source
• Pharmacy
• Medical supervision
• Frequency of follow-up
• Laboratory monitoring
• Treatment response
• Dose individualization
• Availability of the medical team
• What is included in the quoted price

A lower medication price may not represent a lower overall treatment cost if medical services, testing, and monitoring are billed separately.

Conversely, a more expensive treatment program does not automatically mean better medical care.

Families should compare medical quality, safety, transparency, and total cost together.

What Families Should Consider Beyond Cost

Financial considerations matter, but cost should never be the only factor when evaluating pediatric growth treatment.

Growth Potential

A bone age assessment can help determine skeletal maturity and how much growth may remain.

Diagnosis

Conditions and findings such as growth hormone deficiency, low IGF-1, and pituitary disorders require different evaluation and treatment approaches.

Growth Velocity

Children with poor growth velocity may benefit from closer evaluation.

A child's growth pattern over time is often more informative than a single height measurement.

Remaining Growth Window

Growth opportunities decrease as skeletal maturation progresses and growth plates approach closure.

This is why families researching:

• signs your child may need growth hormone testing
• child height prediction calculator for parents
• how tall will my child be
• child height genetics vs hormones

often benefit from a comprehensive assessment before making decisions about treatment.

How to Estimate Your Child's Long-Term Growth Hormone Cost

Families can create a reasonable estimate using several pieces of information.

1. Estimate Medication Cost

Ask what the expected medication expense is based on the child's current prescribed dose.

2. Determine Medical Management Costs

Ask whether appointments and ongoing medical management are included or billed separately.

3. Account for Testing and Imaging

Determine whether laboratory testing and bone age imaging will create additional expenses.

4. Estimate Treatment Duration

Ask how the child's:

• Age
• Bone age
• Pubertal stage
• Diagnosis
• Growth velocity
• Remaining growth potential

may influence the expected treatment window.

5. Account for Future Changes

Remember that medication requirements, pharmacy prices, insurance coverage, and dosage can change.

This approach will not produce an exact lifetime cost, but it provides a much more useful financial estimate than looking only at the first month's medication price.

Questions to Ask Before Paying for Growth Hormone Treatment

Before beginning a potentially multi-year growth hormone program, parents may want to ask:

• What is my child's diagnosis?
• Does my child actually meet criteria for treatment?
• How much growth potential remains?
• What is my child's bone age?
• How long might treatment realistically continue?
• What is the estimated medication expense?
• Could the dose increase as my child grows?
• Are medical visits included?
• Are laboratory tests included?
• Are bone age X-rays included?
• Does insurance cover any portion of treatment?
• Could the preferred medication change?
• Are there pharmacy or supply expenses?
• How frequently will treatment effectiveness be evaluated?
• What happens if treatment is not producing the expected response?
• What expenses should we anticipate beyond medication?

Getting answers to these questions before treatment can help prevent financial surprises later.

Is Growth Hormone Treatment Worth the Cost?

There is no universal answer.

The value of treatment depends heavily on the child's diagnosis and expected benefit.

For a child with established growth hormone deficiency, the medical considerations may be very different from those involving a healthy child with idiopathic short stature or constitutional growth delay.

Parents should therefore be cautious about evaluating growth hormone purely in terms of “cost per inch.”

Treatment decisions should consider:

• Medical indication
• Expected growth response
• Remaining growth potential
• Treatment burden
• Safety
• Treatment duration
• Family preferences
• Financial impact

Growth response can also vary substantially between children.

Appropriate patient selection and ongoing monitoring are therefore essential when considering the medical and financial value of long-term treatment.

The Bottom Line

The long-term cost of growth hormone treatments in kids can be substantial.

Because treatment may continue for several years, cumulative expenses can reach tens of thousands of dollars and, in some circumstances, considerably more.

However, there is no universal price for pediatric growth hormone therapy.

The amount a family actually pays depends on:

• Diagnosis
• Medication
• Dose
• Body weight
• Pharmacy pricing
• Insurance coverage
• Medical management
• Laboratory monitoring
• Treatment duration

Parents should therefore evaluate more than the monthly medication price.

The most useful questions are:

Does my child actually need treatment?

How much growth potential remains?

How many years might treatment continue?

What expenses are included in the treatment program?

What is our realistic long-term out-of-pocket cost?

Most importantly, treatment decisions should begin with an accurate diagnosis.

Understanding whether a child has growth hormone deficiency, idiopathic short stature, constitutional growth delay, low IGF-1, a pituitary disorder, or another cause of slow growth helps families determine whether treatment is medically appropriate before making a significant financial commitment.

The best treatment plan begins with understanding the child's growth pattern, diagnosis, skeletal maturity, expected benefit, remaining growth window, and long-term financial implications.

Medically Reviewed By

Dr. Devin Stone, ND

Dr. Devin Stone is a Doctor of Naturopathic Medicine and founder of HGHforChildren.com. His clinical focus includes pediatric growth evaluation, growth hormone deficiency screening, delayed bone age assessment, constitutional growth delay, IGF-1 interpretation, poor growth velocity, and evidence-informed treatment planning for children and adolescents with growth concerns.

Through HGHforChildren.com, Dr. Stone helps families understand childhood growth patterns, diagnostic testing, bone age, height prediction, treatment options, and the potential short- and long-term financial considerations associated with pediatric growth programs.

Treatment recommendations should be individualized according to the child's medical history, growth pattern, laboratory findings, skeletal maturity, and clinical indication.

Medical References & Clinical Evidence

1. Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Hormone Research in Paediatrics. 2016;86(6):361–397. doi:10.1159/000452150.
   This is probably the most important clinical reference for the article. It supports pediatric GH indications, individualized dosing, monitoring, treatment response, safety, and decision-making.
   PubMed – Pediatric Growth Hormone Treatment Guidelines
2. Collett-Solberg PF, Ambler G, Backeljauw PF, et al. Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective. Hormone Research in Paediatrics. 2019;92(1):1–14. doi:10.1159/000502231.
   Excellent support for the sections explaining why diagnosis comes before treatment, growth velocity, bone age, short-stature evaluation, and appropriate use of GH.
   PubMed – Diagnosis and Treatment of Short Stature
3. Lee JM, Davis MM, Clark SJ, Hofer TP, Kemper AR. Estimated Cost-Effectiveness of Growth Hormone Therapy for Idiopathic Short Stature. Archives of Pediatrics & Adolescent Medicine. 2006;160(3):263–269. doi:10.1001/archpedi.160.3.263.
   This is one of the best references for the financial portion of your article. The economic model estimated approximately $99,959 in incremental cost over five years under its assumptions and demonstrated how treatment duration and dosing can materially affect overall cost. Because the analysis used historical pricing, I would cite it as evidence of the substantial long-term economic burden, not as a current 2026 price quote.
   JAMA Pediatrics – Cost-Effectiveness of GH Therapy
4. Cohen P, Rogol AD, Deal CL, et al. Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature. Journal of Clinical Endocrinology & Metabolism. 2008;93(11):4210–4217. doi:10.1210/jc.2008-0509.
   Particularly useful because your article discusses idiopathic short stature. It supports distinguishing ISS from GHD and reinforces that treatment decisions should consider diagnosis, potential benefit, and individual circumstances.
   PubMed – Idiopathic Short Stature Consensus Statement
5. Growth Hormone Research Society. Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society. Journal of Clinical Endocrinology & Metabolism. 2000;85(11):3990–3993.
   A foundational reference supporting diagnosis, treatment, and monitoring of pediatric GHD.
   JCEM – Growth Hormone Deficiency Consensus Guidelines
6. Pediatric Endocrine Society. Growth Hormone Deficiency: A Guide for Families.
   Useful for parent-facing explanations of poor growth, IGF-1, bone age, GH stimulation testing, recombinant growth hormone treatment, dosing, monitoring, and potential adverse effects.
   Pediatric Endocrine Society – Growth Hormone Deficiency
7. Endocrine Society. Growth Hormone Deficiency.
   Another strong authoritative source supporting the general sections explaining GH/IGF-1 physiology, evaluation, bone age, stimulation testing, treatment, and follow-up.
   Endocrine Society – Growth Hormone Deficiency
8. Endocrine Society. Growth and Short Stature.
   Useful for supporting the distinction between normal familial short stature, constitutional delay, poor growth, and pathologic causes of short stature—particularly relevant to your section explaining why not every short child needs expensive treatment.
   Endocrine Society – Growth and Short Stature